Michael Sassano & Antonio Guedelha: GMP#19 – Pharmaceutical Oral Cannabis Drops Product Development
GMP#19 – Pharmaceutical Oral Cannabis Drops Product Development
Authored By: Michael Sassano & Antonio Guedelha
In the pharmaceutical industry, all products must be approved by the local authorities of the countries where manufacturers will sell them. For pharmaceutical cannabis products, different countries in the European Union have disparate requirements.
For example, Germany only allows magistrally prepared oral cannabinoid drops, while Portugal enables companies to register finished-form oral drops. Understanding the laws in your target countries is imperative for your company’s success.